Home›Companies›Biotech & Pharma›Celestia Diagnostics

Celestia Diagnostics Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 16, 2025·Suggest an edit

About Celestia Diagnostics

Celestia Diagnostics is a private company based in Birmingham, Alabama, incorporated in 2022 in Delaware. It has reported $0 raised in one offering on Form D since October 2025. Its chief executive is Menachem Fishman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetOct 16, 2025$0of $1.5M target0—Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Celestia Diagnostics's Form D filed Oct 16, 2025.

Sources

  1. SECCelestia Diagnostics Inc. filing history